Outthinc

Request quote

alpha lipoic acid

DESCRIPTION

Alpha-Lipoic Acid (ALA), also known as thioctic acid, is an organosulfur compound derived from octanoic acid. It acts as a powerful antioxidant and is widely used in managing diabetic neuropathy, oxidative stress, and other conditions where free radicals are implicated.

MECHANISM OF ACTION

  • Antioxidant Activity: Alpha-Lipoic Acid is unique in that it functions in both aqueous (water-soluble) and lipid (fat-soluble) environments. This broad spectrum of action allows it to neutralize free radicals in various parts of the body, including cellular membranes and cytoplasm.

  • Regeneration of Other Antioxidants: ALA plays a crucial role in the regeneration of other antioxidants, such as vitamin C, vitamin E, and glutathione. This contributes to maintaining the body’s redox balance and reducing oxidative stress.

  • Mitochondrial Coenzyme: ALA acts as a coenzyme for mitochondrial enzyme complexes, particularly pyruvate dehydrogenase and α-ketoglutarate dehydrogenase, both of which are involved in energy metabolism. These enzymes are important in the citric acid cycle (Krebs cycle), where ALA facilitates the production of ATP.

  • Insulin Sensitizer: ALA improves insulin sensitivity by enhancing glucose uptake in muscle cells and activating pathways that increase glucose transporters (GLUT-4), making it useful in managing conditions like diabetes.

CHEMICAL STRUCTURE

  • IUPAC Name: 5-(1,2-dithiolan-3-yl)pentanoic acid

  • Molecular Formula: C8H14O2S2

  • Molecular Weight: 206.33 g/mol 

  • Chemical Class: Organosulfur compound

  • Alpha-Lipoic Acid consists of an eight-carbon dithiol chain with two sulfur atoms in the form of a disulfide ring. It has both oxidized (disulfide) and reduced (dithiol) forms, which are essential for its biological activity as an antioxidant.

FORMULATION METHODS

  • R-ALA vs. S-ALA: Alpha-Lipoic Acid exists as two

    enantiomers, R-lipoic acid (the naturally occurring form) and S-lipoic acid (synthetic). R-lipoic acid is the biologically active form and has greater efficacy.

    Some formulations use a racemic mixture (both R- and S- enantiomers), while others use pure R-ALA for enhanced potency and bioavailability.

  • Absorption and Bioavailability: Oral Alpha-Lipoic Acid is absorbed in the small intestine. However, its bioavailability is relatively low due to extensive first- pass metabolism in the liver. Formulation strategies to improve its bioavailability include:
    Nanoemulsion systems or liposomal formulations that enhance absorption by protecting ALA from degradation and facilitating its delivery across biological membranes. Sustained-release formulations that provide a steady supply of ALA to maintain prolonged antioxidant activity.
  • Dual Solubility: As both a water- and fat-soluble antioxidant, ALA can cross cell membranes and access different cellular compartments, which is a unique property among antioxidants. This versatility allows it to neutralize free radicals both in the plasma membrane and inside cells.

TECHNOLOGICAL ADVANTAGE

  • Liposomal and Nanoemulsion Formulations: These advanced drug delivery systems are used to enhance the oral bioavailability of Alpha-Lipoic Acid by protecting the molecule from degradation and improving absorption.
  • Sustained-release formulations: These provide a continuous release of ALA over time, helping to maintain stable plasma concentrations and prolong its antioxidant effects.
  • R-ALA Supplements: The focus has shifted towards developing pure R- lipoic acid supplements, which are more potent and have higher bioavailability than racemic mixtures.

CLINICAL APPLICATION

  • Managing diabetic neuropathy: ALA helps reduce symptoms like pain, burning, and numbness by improving nerve function and reducing oxidative stress in peripheral nerves.
  • Antioxidant therapy: It is used to mitigate the effects of oxidative stress in conditions as cardiovascular diseases, neurodegenerative disorders (e.g., Alzheimer’s disease), and liver diseases.
  • Anti-inflammatory properties: ALA inhibits pro-inflammatory pathways, helping reduce chronic inflammation associated with metabolic disorders.
  • Heavy metal chelation: ALA can bind and help excrete toxic metals like mercury and arsenic, making it useful in detoxification protocols.

PHARMACOKINETICS

  • Absorption: Alpha-Lipoic Acid is absorbed primarily in the upper gastrointestinal tract. The peak plasma concentration is reached within 30-60 minutes after oral administration, but its bioavailability is low (around 20-40%) due to rapid metabolism.
  • Distribution: Once absorbed, ALA is widely distributed across various tissues, particularly the liver, heart, and skeletal muscles, where it participates in energy production and antioxidant processes.
  • Metabolism: ALA undergoes rapid hepatic metabolism, primarily through beta-oxidation and conjugation reactions. It is metabolized to dihydrolipoic acid (DHLA), the reduced form, which also exhibits antioxidant properties.
  • Excretion: Alpha-Lipoic Acid and its metabolites are primarily excreted through the kidneys in urine.